The European Medicines Agency conditionally approves the use of the Pfizer anti-COVID-19 oral drug Paxlovid for high-risk adult patients. (France 24) European Union response to the COVID-19 pandemic, COVID-19 drug developmentCOVID-19 pandemic in EuropeCOVID-19 pandemic link embed save